Log In
Print
BCIQ
Print
Print this Print this
 

Proellex-V, telapristone (Vaginal Proellex)

  Manage Alerts
Collapse Summary General Information
Company Repros Therapeutics Inc.
DescriptionVaginally delivered selective progesterone receptor modulator (SPRM)
Molecular Target Progesterone receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Genitourinary (unspecified)
Indication DetailsReduce fibroid size; Treat uterine fibroids; Treat uterine fibroids and endometriosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today